Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POLF in Gemcitabine-Refractory Advanced Pancreatic Cancer
NCT00323583Phase 2Unknown
- Start
- May 2006
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, oxaliplatin, folinic acid, fluorouracil in pancreatic adenocarcinoma (PDAC). Status: unknown.
02
Drugs
paclitaxeloxaliplatinfolinic acidfluorouracil
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00323583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323583.